Quantcast
Channel: Liftstream » Sanofi
Browsing all 9 articles
Browse latest View live

Rare Disease Year in Review

This year has been a tumultuous year for the rare diseases market with a number of significant news stories revolving around M&A rumours, regulatory approvals, IPO’s, investments and partnering...

View Article



Ultragenyx focused on ultra-rare disease future

Authored by Paul Foster As part of Liftstream’s commitment to rare diseases, in the run up to Rare Disease Day 2013 we will be profiling 10 companies that are leading the rare disease research effort....

View Article

Sanofi Suffers Setback with two drugs

Authored by James Sheppard Sanofi suffered multiple failures as it chose to drop two drugs. Lung cancer drug iniparib and anticoagulant otamixaban both ceased development after negative phase III data....

View Article

Pharma marries VCs to give birth to Biotechs

Authored by Karl Simpson A marriage made of true love or one of convenience. Whichever, these consummations between pharma and venture capitalists are increasingly frequent and in recent weeks we’ve...

View Article

Massachusetts biotech continues to excite with new investments

Authored by Karl Simpson Massachusetts is a booming biotech cluster and this week has seen a number of funding events that once again signal the level of innovation and investor interest the cluster...

View Article


Academic and industry partnerships drive new Gene Therapy push

Authored by James Sheppard There are many areas of pharmaceutical innovation currently receiving considerable attention, both for their scientific potential in a personalised medicine era but equally...

View Article

Osiris sells stem cell business in $100m deal

Authored by James Sheppard The US based biotechnology company Osiris Therapeutics has announced a $100m deal with Australian biotech Mesoblast for the company to buy its stem cell platform. The deal...

View Article

Sanofi appoint Chief Patient Officer

Authored by James Sheppard The French pharmaceutical giant Sanofi recently announced that it had appointed Dr Anne C. Beal as its new Chief Patient Officer. This is a new role within Sanofi and one...

View Article


Executive Recruitment Round-up October 2014

Authored by James Sheppard Atlas ventures appointed Jason Rhodes as a Partner in its life sciences team. Jason arrives at Atlas from Epizyme where he was President and Chief Financial Officer (CFO). At...

View Article

Browsing all 9 articles
Browse latest View live




Latest Images